Bronchitis and Asthma

  • Esther L. Langmack
  • Richard J. Martin


Cough is the most common problem for which patients seek medical attention in the United States [1]. Asthma and bronchitis are important considerations in the diagnosis of acute and chronic cough. Sputum production is often a feature of cough in asthma and bronchitis, due to abnormalities in pulmonary mucus production and mucociliary clearance in both conditions. Distinguishing between asthma, bronchitis, and other diseases associated with acute or chronic cough can be challenging. This chapter describes the pathophysiology of sputum production in asthma, the work-up of asthma in the coughing patient, and an approach to refractory cough in the patient previously diagnosed with asthma.


Chronic Obstructive Pulmonary Disease Asthmatic Patient Respir Crit Chronic Cough Airflow Limitation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Schappert SM: National Ambulatory Medical Care Survey: 1991 summary. Adv Data 1993, 29:1–16.Google Scholar
  2. 2.
    Benatar SR: Fatal asthma. N Engl J Med 1986, 314:423–429.PubMedCrossRefGoogle Scholar
  3. 3.
    Lange P, Parner J, Vestbo J, et al.: A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998, 339:1194–1200.PubMedCrossRefGoogle Scholar
  4. 4.
    Wanner A, Salathe M, O’Riordan TG: Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996, 154:1868–1902.PubMedCrossRefGoogle Scholar
  5. 5.
    Irwin RS, Boulet LP, Cloutier MM, et al.: Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998, 114:133S–181S. Comprehensive, evidence-based recommendations on the topics of cough mechanisms, diagnosis of cough, and treatment of common causes of chronic cough.PubMedCrossRefGoogle Scholar
  6. 6.
    Ordonez CL, Khashayar R, Wong HH, et al.: Mild and moderate asthma is associated with airway goblet cell hyperplasia and abnormalities in mucin gene expression. Am J Respir Crit Care Med 2001, 163:517–523.PubMedCrossRefGoogle Scholar
  7. 7.
    Carroll N, Elliot J, Morton A, et al.: The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993, 147:405–410.PubMedCrossRefGoogle Scholar
  8. 8.
    Fahy JV, Steiger DJ, Liu J, et al.: Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993, 147:1132–1137.PubMedCrossRefGoogle Scholar
  9. 9.
    Goodman RM, Yergin BM, Landa JF, et al.: Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis. Am Rev Respir Dis 1978, 117:205–214.PubMedGoogle Scholar
  10. 10.
    Regnis JA, Robinson M, Bailey DL, et al.: Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994, 150:66–71.PubMedCrossRefGoogle Scholar
  11. 11.
    Del Donno M, Bittesnich D, Chetta A, et al.: The effect of inflammation on mucociliary clearance in asthma: an overview. Chest 2000, 118:1142–1149.PubMedCrossRefGoogle Scholar
  12. 12.
    Mezey RJ, Cohn MA, Fernandez RJ, et al.: Mucociliary transport in allergic patients with antigen-induced bronchospasm. Am Rev Respir Dis 1978, 118:677–684.PubMedGoogle Scholar
  13. 13.
    Pavia D, Bateman JR, Sheahan NF, et al.: Tracheobronchial mucociliary clearance in asthma: impairment during remission. Thorax 1985, 40:171–175.PubMedCrossRefGoogle Scholar
  14. 14.
    Bateman JR, Pavia D, Sheahan NF, et al.: Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax 1983, 38:463–467.PubMedCrossRefGoogle Scholar
  15. 15.
    Foster WM, Langenback EG, Bergofsky EH: Lung mucociliary function in man: interdependence of bronchial and tracheal mucus transport velocities with lung clearance in bronchial asthma and healthy subjects. Ann Occup Hyg 1982, 26:227–244.PubMedCrossRefGoogle Scholar
  16. 16.
    O’Riordan TG, Zwang J, Smaldone GC: Mucociliary clearance in adult asthma. Am Rev Respir Dis 1992, 146:598–603.PubMedCrossRefGoogle Scholar
  17. 17.
    Messina MS, O’Riordan TG, Smaldone GC: Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis 1991, 143:993–997.PubMedCrossRefGoogle Scholar
  18. 18.
    Khashayar R, Zhao C, Wong HH, et al.: Effect of allergen challenge on airway epithelial mucin stores in asthmatic subjects. Am J Respir Crit Care Med 2000, 161:A204.Google Scholar
  19. 19.
    Marom Z, Shelhamer JH, Bach MK, et al.: Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 1982, 126:449–451.PubMedGoogle Scholar
  20. 20.
    Coles SJ, Neill KH, Reid LM, et al.: Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. Prostaglandins 1983, 25:155–170.PubMedGoogle Scholar
  21. 21.
    Marin MG, Davis B, Nadel JA: Effect of histamine on electrical and ion transport properties of tracheal epithelium. J Appl Physiol 1977, 42:735–738.PubMedGoogle Scholar
  22. 22.
    Webber SE, Widdicombe JG: The actions of methacholine, phenylephrine, salbutamol and histamine on mucus secretion from the ferret in-vitro trachea. Agents Actions 1987, 22:82–85.PubMedCrossRefGoogle Scholar
  23. 23.
    Ahmed T, Greenblatt DW, Birch S, et al.: Abnormal mucociliary transport in allergic patients with antigen-induced bronchospasm: role of slow reacting substance of anaphylaxis. Am Rev Respir Dis 1981, 124:110–114.PubMedGoogle Scholar
  24. 24.
    Gonzales R, Bartlett JG, Besser RE, et al.: Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001, 134:521–529. Position paper for the American College of Physicians providing evidence-based recommendations for the evaluation and treatment of uncomplicated acute bronchitis, including a detailed discussion of the use of antibiotics.PubMedCrossRefGoogle Scholar
  25. 25.
    Gonzales R, Barrett PH, Jr, Steiner JF: The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections. J Gen Intern Med 1999, 14:151–156.PubMedCrossRefGoogle Scholar
  26. 26.
    Jonsson JS, Gislason T, Gislason D, et al.: Acute bronchitis and clinical outcome three years later: prospective cohort study. BMJ 1998, 317:1433.PubMedCrossRefGoogle Scholar
  27. 27.
    Thiadens HA, Postma DS, de Bock GH, et al.: Asthma in adult patients presenting with symptoms of acute bronchitis in general practice. Scand J Prim Health Care 2000, 18:188–192.PubMedCrossRefGoogle Scholar
  28. 28.
    Williamson HA Jr, Schultz P: An association between acute bronchitis and asthma. J Fam Pract 1987, 24:35–38.PubMedGoogle Scholar
  29. 29.
    Hueston WJ, Mainous AG 3rd: Acute bronchitis. Am Fam Physician 1998, 57:1270–1276, 1281–1272.PubMedGoogle Scholar
  30. 30.
    Williamson HA Jr: Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 1987, 25:251–256.PubMedGoogle Scholar
  31. 31.
    Melbye H, Kongerud J, Vorland L: Reversible airflow limitation in adults with respiratory infection. Eur Respir J 1994, 7:1239–1245.PubMedCrossRefGoogle Scholar
  32. 32.
    Hueston WJ: Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994, 39:437–440.PubMedGoogle Scholar
  33. 33.
    Melbye H, Aasebo U, Straume B: Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study. Fam Pract 1991, 8:216–222.PubMedCrossRefGoogle Scholar
  34. 34.
    Johnston SL, Pattemore PK, Sanderson G, et al.: Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. BMJ 1995, 310:1225–1229.PubMedCrossRefGoogle Scholar
  35. 35.
    Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. BMJ 1993, 307:982–986.PubMedCrossRefGoogle Scholar
  36. 36.
    Johnston SL, Pattemore PK, Sanderson G, et al.: The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996, 154:654–660.PubMedCrossRefGoogle Scholar
  37. 37.
    Corne JM, Marshall C, Smith S, et al.: Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831–834.PubMedCrossRefGoogle Scholar
  38. 38.
    Gern JE, Busse WW: The role of viral infections in the natural history of asthma. J Allergy Clin Immunol 2000, 106:201–212. Evidence linking respiratory viral infections to the development, exacerbation, and persistence of asthma.PubMedCrossRefGoogle Scholar
  39. 39.
    Senior BA, Kennedy DW: Management of sinusitis in the asthmatic patient. Ann Allergy Asthma Immunol 1996, 77:6–15; quiz 15–19.PubMedCrossRefGoogle Scholar
  40. 40.
    Kraft M: The role of bacterial infections in asthma. Clin Chest Med 2000, 21:301–313. Detailed review of studies linking infection with Mycoplasma pneumoniae and Chlamydia pneumoniae with the development of asthma.PubMedCrossRefGoogle Scholar
  41. 41.
    Hahn DL, Dodge RW, Golubjatnikov R: Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991, 266:225–230.PubMedCrossRefGoogle Scholar
  42. 42.
    Gil JC, Cedillo RL, Mayagoitia BG, et al.: Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy 1993, 70:23–25.PubMedGoogle Scholar
  43. 43.
    Martin RJ, Kraft M, Chu HW, et al.: A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001, 107:595–601.PubMedCrossRefGoogle Scholar
  44. 44.
    National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program: Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, Pub. No. 97–4051; 1997. Practice standards for the diagnosis and treatment of asthma in children and adults, in the clinic, emergency department and hospital. New NHLBI guidelines are anticipated in 2002.Google Scholar
  45. 45.
    Pincus DJ, Beam WR, Martin RJ: Chronobiology and chronotherapy of asthma. Clin Chest Med 1995, 16:699–713.PubMedGoogle Scholar
  46. 46.
    Pauwels RA, Buist AS, Ma P, et al.: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001, 46:798–825. Current recommendations for the diagnosis and management of chronic obstructive pulmonary disease. Also known as the “GOLD guidelines.” PubMedGoogle Scholar
  47. 47.
    Irwin RS, Corrao WM, Pratter MR: Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981, 123:413–417.PubMedGoogle Scholar
  48. 48.
    Irwin RS, Madison JM: The persistently troublesome cough. Am J Respir Crit Care Med 2002, 165:1469–1474.Common pitfalls in the work-up of the patient with chronic cough, with particular attention to the diagnosis of eosinophilic bronchitis, postnasal drip syndrome, asthma, and GERD.PubMedCrossRefGoogle Scholar
  49. 49.
    Irwin RS, Curley FJ, French CL: Chronic cough. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 1990, 141:640–647.PubMedCrossRefGoogle Scholar
  50. 50.
    Mello CJ, Irwin RS, Curley FJ: Predictive values of the character, timing, and complications of chronic cough in diagnosing its cause. Arch Intern Med 1996, 156:997–1003.PubMedCrossRefGoogle Scholar
  51. 51.
    Smyrnios NA, Irwin RS, Curley FJ: Chronic cough with a history of excessive sputum production. The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Chest 1995, 108:991–997.PubMedCrossRefGoogle Scholar
  52. 52.
    Johnson D, Osborn LM: Cough variant asthma: a review of the clinical literature. J Asthma 1991, 28:85–90.PubMedCrossRefGoogle Scholar
  53. 53.
    American Thoracic Society: Lung function testing: selection of reference values and interpretation strategies. Am Rev Respir Dis 1991, 144:1202–1218.CrossRefGoogle Scholar
  54. 54.
    Cheriyan S, Greenberger PA, Patterson R: Outcome of cough variant asthma treated with inhaled steroids. Ann Allergy 1994, 73:478–480.PubMedGoogle Scholar
  55. 55.
    Brightling CE, Pavord ID: Eosinophilic bronchitis: an important cause of prolonged cough. Ann Med 2000, 32:446–451.PubMedCrossRefGoogle Scholar
  56. 56.
    Christopher KL, Wood RP 2nd, Eckert RC, et al.: Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983, 308:1566–1570.PubMedCrossRefGoogle Scholar
  57. 57.
    Barker AF: Bronchiectasis. N Engl J Med 2002, 346:1383–1393.PubMedCrossRefGoogle Scholar
  58. 58.
    Jeffery PK: Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley Lecture. Chest 2000, 117:251S–260S. Review of airway tissue histopathology and cellular inflammation in COPD and asthma, pointing out important differences between these two common diseases.PubMedCrossRefGoogle Scholar
  59. 59.
    Dompeling E, van Schayck CP, Molema J, et al.: Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992, 5:945–952.PubMedGoogle Scholar
  60. 60.
    Pizzichini E, Pizzichini MM, Gibson P, et al.: Sputum eosinophil-ia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med 1998, 158:1511–1517.PubMedCrossRefGoogle Scholar
  61. 61.
    Schaefer OP, Irwin RS: Chronic cough due to clinically “silent” suppurative disease of the airways: a new clinical entity. Am J Respir Crit Care Med 1999, 159:A830.Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Esther L. Langmack
  • Richard J. Martin

There are no affiliations available

Personalised recommendations